Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ZYBT

Zhengye Biotechnology Holding Ltd

CIK 0001975641 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.04
↑ 0.15 (7.94%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 1/4 lenses
FundamentalsOwnershipTechnicalsOptions

Signals mixed across all four lenses; Excluded: Fundamentals, Ownership, Options (no data)

Key stats

Market Cap
$96.68M
P/E Ratio
Not covered
EPS
Not covered
Dividend Yield
Not covered
52W Position
11%
Beta
-0.74

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 11%
$0.62$13.08

Latest Financials

2025-12-31 FY
Revenue
$116.36M
Net Income
-$69.78M
Total Assets
$436.47M
Free Cash Flow
$12.32M

Recent news